Lobbying client
PEPTIDE SCIENCES
Life sciences education and development of physician-led telemedicine healthcare platform
Filings
3
Filed by
1
Reported in-house
—
Reported by firms
$360,000
Filings
3 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Report 3rd Quarter 2026
|
MILLER STRATEGIES, LLC | $150,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
MILLER STRATEGIES, LLC | $210,000 reported |
|
Registration 2nd Quarter 2026
|
MILLER STRATEGIES, LLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| MILLER STRATEGIES, LLC | 2 | $360,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 3 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.